Share:
Share this content in WeChat
X
Clinical Article
A quantitative study about iron content of the cerebral nucleus in patients with Parkinson's disease
TANG Shou-xian  ZUO Li-jun  ZHANG Wei  SHEN Hui-cong  DAI Jian-ping 

DOI:10.12015/issn.1674-8034.2016.09.002.


[Abstract] Objective: Aiming to measure and analyse the iron content in cerebral nucleus of the Parkinson's disease (PD) subjects.Materials and Methods: Forty PD subjects and 36 volunteers were recruited in the cross-sectional study. Susceptibility weighted images (SWI) was acquired for all participants. Phase values of globus pallidum (GP), putamen (PUT), substantia nigra (SN) were measured by SPIN software. Paired-sample t test was used to compare the phase values of nucleus, P<0.05 was considered to be statistically significant.Results: Phase values in SN of PD subjects were least (right, 2034.84. left, 2030.55). Phase values of bilateral GP (R, P=0.018. L, P=0.040) and bilateral SN (R, P=0.008. L, P=0.000) showed significantly statistical differences between PD subjects and volunteers. There were significantly statistical differences in phase values between right GP and SN (P=0.000), right PUT and SN (P=0.000), left PUT and SN (P=0.000) in PD subjects.Conclusions: SN showed highest iron content in patients with PD, iron content increased symmetrically in GP and SN of patients with PD. SWI provided information for the diagnosis of PD.
[Keywords] Parkinson disease;Magnetic resonance imaging;Iron

TANG Shou-xian Department of Radiology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China

ZUO Li-jun Department of Geriatric, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China

ZHANG Wei Department of Geriatric, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China

SHEN Hui-cong Department of Radiology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China

DAI Jian-ping* Department of Radiology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China

*Correspondence to: Dai JP, E-mail: daijianping_2008@126.com

Conflicts of interest   None.

ACKNOWLEDGMENTS  This work was part of the General Program of National Natural Science Foundation of China No. 81271541
Received  2016-06-01
Accepted  2016-08-10
DOI: 10.12015/issn.1674-8034.2016.09.002
DOI:10.12015/issn.1674-8034.2016.09.002.

[1]
Hagemeier J, Geurts JJ, Zivadinov R, et al. Brain iron accumulation in aging and neurodegenerative disorders. Expert Rev Neutother, 2012, 12(12): 1467-1480.
[2]
毛磊,戴建平,孙波.磁敏感加权成像观察健康人群脑内铁含量.中国医学影像技术, 2009, 25(6): 996-998.
[3]
Zhang W, Sun SG, Jiang YH, et al. Determination of brain iron content in patients with Parkinson's disease using magnetic susceptibility imaging. Neurosci Bull, 2009, 25(6): 353-360.
[4]
刘太元,白岩,马潇越,等. 3.0 T MR非高分辨ESWAN上黑质"燕尾征"在帕金森病诊断中的价值.磁共振成像, 2016, 7(46):265-269.
[5]
方学文,胡涛,武玉华,等. 1H-MRS检测早期帕金森病纹状体、黑质的功能代谢.磁共振成像, 2015, 6(7): 481-485.
[6]
高俊华,闫兆芬,刘卓,等.铁选择性损伤多巴胺能神经元的神经免疫炎症机制.中华神经科杂志, 2011, 44(7): 493-499.
[7]
Peng J, Peng L, Stevenson FF, et al. Iron and paraquat as synergistic environmental risk factors in sporadic Parkinson's disease accelerate age-related neurodegeneration. J Neurosci, 2007, 27(26): 6914-6922.
[8]
Langkammer C, Krebs N, Goessler W, et al. Quantitative MR imaging of brain iron a postmortem validation study. Radiology, 2010, 257(2): 455-461.
[9]
Schafer A, Forstmann BU, Neumann J, et al. Direct visualization of the subthalamic nucleus and its iron distribution using high-resolution susceptibility mapping. Hum Brain Mapp, 2012, 33(12):2831-2842.
[10]
Huang YW, Jeng JS, Tsai CF, et al. Transcranial imaging of substantia nigra hyperechogenicity in a Taiwanese cohort of Parkinson's disease. Mov Disord, 2007, 22(4): 550-555.
[11]
Haacke EM, Xu Y, Cheng YC, et al. Susceptibility weighted imaging (SWI). Magn Reson Med, 2004, 52(3): 612-618.
[12]
Oakley AE, Collingwood JF, Dobson J, et al. Individual dopaminergic neurons show raised iron levels in Parkinson disease. Neurology, 2007, 68(21): 1820-1825.
[13]
Cosottini M, Frosini D, Pesaresi I, et al. MR imaging of the substantia nigra at 7 T enables diagnosis of Parkinson disease. Radiology, 2014, 271(3): 831-838
[14]
Rossi M, Ruottinen H, Soimakallio S, et al. Clinical MRI for iron detection in Parkinson's disease. Clin Imaging, 2013, 37(4): 631-636.
[15]
Gupta D, Saini J, Kesavadas C, et al. Utility of susceptibility-weighted MRI in differentiating Parkinson's disease and atypical parkinsonism. Neuroradiology, 2010, 52(12): 1087-1094.
[16]
Jin L, Wang J, Zhao L, et al. Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease. Brain, 2011, 134(1): 50-58.
[17]
Wang Y, Butros SR, Shuai X, et al. Different iron-deposition patterns of multiple system atrophy with predominant parkinsonism and idiopathetic Parkinson diseases demonstrated by phase-corrected susceptibility-weighted imaging. AJNR Am J Neuroradiol, 2012,33(2): 266-273.
[18]
Lotfipour AK, Wharton S, Schwarz ST, et al. High resolution magnetic susceptibility mapping of the substantia nigra in Parkinson's disease. J Magn Reson Imaging, 2012, 35(1): 48-55.
[19]
Meijer FJ, van Rumund A, Fasen BA, et al. Susceptibility-Weighted Imaging Improves the Diagnostic Accuracy of 3T Brain MRI in the Work-Up of Parkinsonism. AJNR Am J Neuroradiol, 2015, 36(3):454-460.
[20]
Xu XJ, Wang QD, Zhang MM. Age, gender, and hemispheric differences in iron deposition in the human brain: an in vivo MRI study. Neuroimage, 2008, 40(1): 35-42.

PREV The application of MR oxygen extraction fraction imaging in astrocytoma grading
NEXT Analysis of related parameters of magnetic resonance spectroscopy in the hippocampus of normal middle-aged group
  



Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn